<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03678870</url>
  </required_header>
  <id_info>
    <org_study_id>181190</org_study_id>
    <nct_id>NCT03678870</nct_id>
  </id_info>
  <brief_title>Discharge Opioid Education to Decrease Opioid Use After Cesarean</brief_title>
  <official_title>Discharge Opioid Education to Decrease Opioid Use After Cesarean</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: The number of opioid overdose deaths in the United States has quadrupled in 15
      years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a
      sharp increase in the amount of legal prescription opioids dispensed. The abundance of
      prescription opioids available is a primary pathway for opioid abuse and diversion and higher
      opioid use after surgery has been associated with an increased risk of chronic opioid use.
      Reducing the amount of opioid used after cesarean delivery may decrease the risk of chronic
      opioid use and will help towards better estimating and reducing the amount of opioids
      prescribed at discharge.

      Objective: To to compare discharge opioid education to standard care to ascertain whether
      opioid education reduces opioid use after hospital discharge
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: The number of opioid overdose deaths in the United States has quadrupled in 15
      years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a
      sharp increase in the amount of legal prescription opioids dispensed. The abundance of
      prescription opioids available is a primary pathway for opioid abuse and diversion and higher
      opioid use after surgery has been associated with an increased risk of chronic opioid use.
      Reducing the amount of opioid used after cesarean delivery may decrease the risk of chronic
      opioid use and will help towards better estimating and reducing the amount of opioids
      prescribed at discharge.

      Objective: To to compare discharge opioid education to standard care to ascertain whether
      opioid education reduces opioid use after hospital discharge

      Preliminary Data: Our soon to be published study (Obstetrics &amp; Gynecology Journal) found that
      30% of women used all their opioids after discharge for cesarean delivery because they &quot;were
      following directions&quot; and not because they had pain.

      Enrollment &amp; Randomization

      Enrollment

        -  Participants will be approached after their cesarean delivery either in the recovery
           room or in their private postpartum room

        -  Informed written consent will be obtained by a trained research assistant (i.e. medical
           student) or by the study researchers (Attendings, fellows)

        -  After enrollment, participants will be asked to complete Survey 1 either in person or by
           giving sending them the web link with RedCap

      Randomization

        -  Enrolled patients will be randomized in a 1:1 ratio using permuted blocks of 6

        -  Randomization sequence will be developed through sealed envelope.com

        -  Randomization and allocation will be done through RedCap

      Study Procedures

        1. Enrollment

        2. Postoperative Day 0-1: Survey 1 through RedCap (takes ~10 minutes)

        3. Randomization education versus usual care

             1. Control = Standard discharge instructions, which list medications prescribed at
                discharge

             2. Intervention = a single page handout (see attachment) with information about how to
                use medications for pain after discharge. This handout contains the following
                instructions

                  -  Get baseline pain control with ibuprofen

                  -  Use your opioid prescription only if your pain is very bad

                  -  Taper your medications

                  -  Get rid of leftover opioid tablets

        4. At discharge all patients will receive the follow medications using PillsyCaps. These
           are standard medications given at discharge at our institution

             -  Ibuprofen 600mg: 30 tablets

             -  Hydrocodone 5mg -acetaminophen 325mg: 30 tablets

        5. Postoperative day 14: All participants will be contacted to complete Survey 2 (Takes ~
           15 minutes

             -  Attempts to contact each participant will be done 3 times before they are
                designated as &quot;lost to follow up&quot;

             -  If a participant is still using opioids on postoperative day 14, they should be
                contacted weekly until they are no longer taking opioids

      Primary Outcome Median number of tablets of hydrocodone-acetaminophen used after hospital
      discharge

      Secondary Outcomes:

        -  Visual Analog Scale pain score (median)

        -  Percentage of patients reporting pain since discharge as worse than expected

        -  Percentage of patients obtaining additional prescriptions for pain

        -  Percentage of patients with unscheduled visits for pain

        -  Mean ibuprofen milligrams used hours 24-47 after cesarean

        -  Mean acetaminophen milligrams used hours 24-47 after cesarean

        -  Total Morphine Milligram Equivalents (MME) used per hour of inpatient stay

      Risks

      o Breach of confidentiality of protected health information

      Reporting Adverse Events Any adverse events or unanticipated problems involving risk to
      participants or others will be reported to the Institutional Review Board and the Vanderbilt
      University Medical Center (VUMC) privacy office within 7 days of discovery.

      Study Withdrawal/discontinuation Participants may withdraw at any time by providing written
      intent to the Primary Investigator. Participants may be removed from the study if they
      develop a major surgical complication after their cesarean.

      Statistical Considerations

      Using prior data, the average opioid MME used per person was 130 MME (SD 90) in the &quot;average
      use&quot; group. With an alpha of 5% and a beta of 80%, we estimate that 160 total participants
      are required to show a 30% reduction in opioid used. Assuming a lost to follow up rate of
      20%, we plan to enroll 200 women.

      Follow-up and Record Retention On average 100 cesareans are performed per month. With a 50%
      enrollment rate, we anticipate this study will take 4 months to complete

      The patient list will be destroyed upon data analysis and publication. Redcap will be
      archived upon publication.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">November 1, 2019</completion_date>
  <primary_completion_date type="Actual">February 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Use</measure>
    <time_frame>6 weeks postpartum</time_frame>
    <description>Median number of tablets of hydrocodone-acetaminophen used after hospital discharge</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disposed of Opioids Correctly</measure>
    <time_frame>6 weeks postpartum</time_frame>
    <description>Frequency of women reporting that they either returned their unused opioids to a pharmacy or flushed them down the toilet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic Quiz Score</measure>
    <time_frame>6 weeks postpartum</time_frame>
    <description>Median score on an assessment of characteristics of analgesics including side effects, risks, and benefits. Score 1-10 for each question. Higher score is better.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional Prescriptions</measure>
    <time_frame>6 weeks postpartum</time_frame>
    <description>Percentage of patients obtaining additional prescriptions for pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">196</enrollment>
  <condition>Opioid Use</condition>
  <arm_group>
    <arm_group_label>Education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Opioid Education</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard discharge instructions, which lists medications prescribed at discharge</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Opioid Education Handout</intervention_name>
    <description>a single page handout with information about how to use medications for pain after discharge.</description>
    <arm_group_label>Education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women 18-45 years old

          -  Women undergoing cesarean delivery at VUMC

        Exclusion Criteria:

          -  Major post-surgical complications:

          -  cesarean hysterectomy, bowel or bladder injury, reoperation, ICU admission, wound
             infection or separation

          -  Chronic opioid use: Taking buprenorphine during pregnancy, taking an opioid for &gt; 7
             days during pregnancy.

          -  Women who do not speak English
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women undergoing cesarean delivery at VUMC</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Osmundson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sarah Osmundson</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>September 18, 2018</study_first_submitted>
  <study_first_submitted_qc>September 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2018</study_first_posted>
  <results_first_submitted>January 27, 2020</results_first_submitted>
  <results_first_submitted_qc>January 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 5, 2020</results_first_posted>
  <last_update_submitted>February 4, 2020</last_update_submitted>
  <last_update_submitted_qc>February 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Sarah Osmundson</investigator_full_name>
    <investigator_title>Assistant Professor, Ob/Gyn</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 2, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/70/NCT03678870/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Education</title>
          <description>Opioid Education
Opioid Education Handout: a single page handout with information about how to use medications for pain after discharge.</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Standard discharge instructions, which lists medications prescribed at discharge</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="97"/>
                <participants group_id="P2" count="99"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="84"/>
                <participants group_id="P2" count="91"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>prescribed non- protocol medications</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Education</title>
          <description>Opioid Education
Opioid Education Handout: a single page handout with information about how to use medications for pain after discharge.</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Standard discharge instructions, which lists medications prescribed at discharge</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="84"/>
            <count group_id="B2" value="91"/>
            <count group_id="B3" value="175"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.9" spread="5.4"/>
                    <measurement group_id="B2" value="30.5" spread="4.9"/>
                    <measurement group_id="B3" value="30.2" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="84"/>
                    <measurement group_id="B2" value="91"/>
                    <measurement group_id="B3" value="175"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Caucasian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="112"/>
                  </measurement_list>
                </category>
                <category>
                  <title>African-American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84"/>
                    <measurement group_id="B2" value="91"/>
                    <measurement group_id="B3" value="175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>High school education or less</title>
          <description>Women who completed high school (12th grade) or less</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Opioid Use</title>
        <description>Median number of tablets of hydrocodone-acetaminophen used after hospital discharge</description>
        <time_frame>6 weeks postpartum</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Education</title>
            <description>Opioid Education
Opioid Education Handout: a single page handout with information about how to use medications for pain after discharge.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Standard discharge instructions, which lists medications prescribed at discharge</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Use</title>
          <description>Median number of tablets of hydrocodone-acetaminophen used after hospital discharge</description>
          <units>hydrocodone tablets</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="91"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" lower_limit="2" upper_limit="15"/>
                    <measurement group_id="O2" value="10" lower_limit="2" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Disposed of Opioids Correctly</title>
        <description>Frequency of women reporting that they either returned their unused opioids to a pharmacy or flushed them down the toilet</description>
        <time_frame>6 weeks postpartum</time_frame>
        <population>Denominator includes only women who had leftover opioids</population>
        <group_list>
          <group group_id="O1">
            <title>Education</title>
            <description>Opioid Education
Opioid Education Handout: a single page handout with information about how to use medications for pain after discharge.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Standard discharge instructions, which lists medications prescribed at discharge</description>
          </group>
        </group_list>
        <measure>
          <title>Disposed of Opioids Correctly</title>
          <description>Frequency of women reporting that they either returned their unused opioids to a pharmacy or flushed them down the toilet</description>
          <population>Denominator includes only women who had leftover opioids</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="83"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analgesic Quiz Score</title>
        <description>Median score on an assessment of characteristics of analgesics including side effects, risks, and benefits. Score 1-10 for each question. Higher score is better.</description>
        <time_frame>6 weeks postpartum</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Education</title>
            <description>Opioid Education
Opioid Education Handout: a single page handout with information about how to use medications for pain after discharge.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Standard discharge instructions, which lists medications prescribed at discharge</description>
          </group>
        </group_list>
        <measure>
          <title>Analgesic Quiz Score</title>
          <description>Median score on an assessment of characteristics of analgesics including side effects, risks, and benefits. Score 1-10 for each question. Higher score is better.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="91"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="9" upper_limit="10"/>
                    <measurement group_id="O2" value="8" lower_limit="7" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Additional Prescriptions</title>
        <description>Percentage of patients obtaining additional prescriptions for pain</description>
        <time_frame>6 weeks postpartum</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Education</title>
            <description>Opioid Education
Opioid Education Handout: a single page handout with information about how to use medications for pain after discharge.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Standard discharge instructions, which lists medications prescribed at discharge</description>
          </group>
        </group_list>
        <measure>
          <title>Additional Prescriptions</title>
          <description>Percentage of patients obtaining additional prescriptions for pain</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="91"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Education</title>
          <description>Opioid Education
Opioid Education Handout: a single page handout with information about how to use medications for pain after discharge.</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Standard discharge instructions, which lists medications prescribed at discharge</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="99"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="99"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="99"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sarah Osmundson, Assistant Professor of Obstetrics and Gynecology</name_or_title>
      <organization>Vanderbilt University Medical Center</organization>
      <phone>(615) 343-7869â€¬</phone>
      <email>sarah.osmundson@vumc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

